Evidence map›Paper›PMID 15015036›Full record

ArticleJournal of human genetics2004

Screening for point mutations in the LDL receptor gene in Bulgarian patients with severe hypercholesterolemia.

Vassil A Mihaylov, Anelia D Horvath, Alexey S Savov, Elina F Kurshelova, Ivanka D Paskaleva, Assen R Goudev, Ivaylo R Stoilov, Varban S Ganev

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 19 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Vassil A MihaylovDepartment of Chemistry and Biochemistry, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria.
Anelia D HorvathDepartment of Chemistry and Biochemistry, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria.
Alexey S SavovUniversity Hospital for Obstetrics and Gynaecology, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria.
Elina F KurshelovaDepartment of Propaedeutics of Internal Diseases, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria.
Ivanka D PaskalevaNational Centre of Cardiovascular Diseases, Sofia, Bulgaria.
Assen R GoudevDepartment of Propaedeutics of Internal Diseases, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria.
Ivaylo R StoilovDepartment of Surgery, University of Connecticut Health Center, Farmington, CT, USA.
Varban S GanevDepartment of Chemistry and Biochemistry, Medical University of Sofia, 2 Zdrave Str., Sofia, 1431, Bulgaria. ganev@medfac.acad.bg.
Medical University of Sofia · BGNational Center of Infectious and Parasitic Diseases · BGUConn Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial hypercholesterolemia (FH) is a common, autosomal dominant disorder of lipid metabolism, caused by defects in the receptor-mediated uptake of LDL (low-density lipoproteins) due to mutations in the LDL receptor gene ( LDLR). Mutations underlying FH in Bulgaria are largely unknown. The aim of the present study was to provide information about the spectrum of point mutations in LDLR in a sample of 45 Bulgarian patients with severe hypercholesterolemia. Exons 3, 4, 6, 8, 9, and 14, previously shown to be mutational hot spots in LDLR, were screened using PCR-single-strand conformation polymorphism (SSCP). Samples with abnormal SSCP patterns were sequenced. Three different, hitherto undescribed point mutations (367T>A, 377T>A, 917C>A) and two previously described mutations (858C>A and 1301C>T) in eight unrelated patients were identified; four of the detected point mutations being missense mutations and one, a nonsense mutation. One of the newly described point mutations (917C>A) is a base substitution at a nucleotide position, at which two other different base substitutions have already been reported. Thus, all three possible base substitutions at this nucleotide position have been detected, making it a hot spot for point mutations causing FH. This is the first such mutational hot spot described in exon 6 of LDLR.

Indexed as

Point MutationBulgariaDNADNA Mutational AnalysisGenetic TestingHumansHypercholesterolemiaMalePolymerase Chain ReactionPolymorphism, Single-Stranded ConformationalReceptors, LDLDNAReceptors, LDL

Identifiers

PMID15015036
OpenAlexW2019156136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.